Search This Blog

Tuesday, July 30, 2019

Amgen EPS beats by $0.39, beats on revenue

Amgen (NASDAQ:AMGN): Q2 Non-GAAP EPS of $3.97 beats by $0.39; GAAP EPS of $3.57 beats by $0.39.
Revenue of $5.87B (-3.1% Y/Y) beats by $200M.
Shares +0.8%.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.